General

Showing 49–64 of 1288 results

• 

  Article: ALK-inhibitors in NSCLC: a tabulated review of randomised phase III trials

  €3.03 Add to cart
• 

  Article: All.Can Belgium Lung Cancer Working Group: Ready for take-off

  €3.03 Add to cart
• 

  Article: Amivantamab plus lazertinib as a first-line treatment for patients with -mutant advanced NSCLC

  €3.03 Add to cart
• 

  Article: AN EXPERT’S OPINION

  €3.03 Add to cart
• 

  Article: AN EXPERT’S OPINION

  €3.03 Add to cart
• 

  Article: An unusual complete remission of a diffuse metastatic squamous cell cutaneous carcinoma with an EGFR-TKI

  €3.03 Add to cart
• 

  Article: An update on the management of metastatic clear-cell renal cell carcinoma: the BSMO expert panel recommendations

  €3.03 Add to cart
• 

  Article: An update on the systemic treatment of renal cell cancer

  €3.03 Add to cart
• 

  Article: An update on the systemic treatment of renal cell cancer

  €3.03 Add to cart
• 

  Article: An update on the systemic treatment of renal cell cancer

  €3.03 Add to cart
• 

  Article: Angioedema of the tongue in a patient with breast carcinoma treated with exemestane-everolimus in combination with an angiotensinconverting enzyme inhibitor

  €3.03 Add to cart
• 

  Article: Antibody-drug conjugates in lung cancer: a paradigm shift on the horizon?

  €3.03 Add to cart
• 

  Article: Antibody-drug conjugates in the treatment of advanced breast cancer

  €3.03 Add to cart
• 

  Article: Appropriateness and optimal sequence of treatments for metastatic castration-resistant prostate cancer: Outcomes of a Belgian and Dutch multidisciplinary consensus meeting

  €3.03 Add to cart
• 

  Article: Appropriateness of treatment options in patients with metastatic castrationresistant prostate cancer with a focus on radium-223: outcomes of a Belgian multidisciplinary Consensus Meeting

  €3.03 Add to cart
• 

  Article: Are patients better treated in clinical trials?

  €3.03 Add to cart